Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
61.05
+0.05 (0.08%)
Jul 2, 2026, 3:15 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,1372,2242,436---
Market Cap Growth
-10.82%-8.70%----
Enterprise Value
2,2012,2672,496---
Last Close Price
61.0562.6967.43---
PE Ratio
20.4522.9330.51---
Forward PE
-22.9824.86---
PS Ratio
4.334.836.18---
PB Ratio
5.125.346.62---
P/TBV Ratio
5.416.297.67---
P/FCF Ratio
40.0630.16111.20---
P/OCF Ratio
27.8825.1273.65---
EV/Sales Ratio
4.464.926.33---
EV/EBITDA Ratio
17.4619.0325.19---
EV/EBIT Ratio
19.1121.2027.95---
EV/FCF Ratio
41.2730.74113.93---
Debt / Equity Ratio
0.200.150.170.200.300.33
Debt / EBITDA Ratio
0.660.540.640.731.111.05
Debt / FCF Ratio
1.560.872.890.861.443.44
Net Debt / Equity Ratio
0.160.070.110.150.220.26
Net Debt / EBITDA Ratio
0.510.250.410.550.800.82
Net Debt / FCF Ratio
1.210.401.850.651.042.69
Asset Turnover
0.840.820.800.760.700.73
Inventory Turnover
1.911.771.681.441.371.45
Quick Ratio
2.092.241.851.491.361.59
Current Ratio
2.853.132.652.362.222.30
Return on Equity (ROE)
25.96%24.73%23.67%22.44%21.72%25.52%
Return on Assets (ROA)
12.26%11.87%11.39%10.83%10.10%12.09%
Return on Invested Capital (ROIC)
23.18%23.40%21.67%20.57%18.76%22.59%
Return on Capital Employed (ROCE)
24.20%22.90%22.70%23.40%22.30%25.40%
Earnings Yield
4.89%4.36%3.28%---
FCF Yield
2.50%3.32%0.90%---
Dividend Yield
2.27%2.21%1.70%---
Payout Ratio
46.31%48.43%18.79%54.69%61.14%56.12%
Total Shareholder Return
2.27%2.21%1.70%---